Sign up now to have the right to view
50 tenders for free.
Title |
Innovation Grants To Nurture Initial Translational Efforts (Ignite): Neurotherapeutic Agent Characterization And In Vivo Efficacy Studies (R61 R33 Clinical Trial Not Allowed) Tender Notice International Competitive Bidding |
|||
---|---|---|---|---|
You can sign up and unlock it for freeAccess to Public and Private Sector Business Opportunities for 200+ Countries |
||||
Country | ||||
Language | English | |||
Organization | ||||
Published Date | 23.10.2024 | |||
Deadline Date | 20.10.2027 | |||
Overview |
Innovation Grants To Nurture Initial Translational Efforts (Ignite): Neurotherapeutic Agent Characterization And In Vivo Efficacy Studies (R61 R33 Clinical Trial Not Allowed) Reissue Par-21-122. This Nofo Provides Funding To Conduct Pharmacodynamic, Pharmacokinetic, And In Vivo Efficacy Studies To Demonstrate That Proposed Therapeutic Agent(S) Have Sufficient Biological Activity To Warrant Further Development To Treat Neurological Or Neuromuscular Disorders That Fall Under The Ninds Mission. Therapeutic Agents Include Small Molecules, Biologics Or Biotechnology-Derived Products. This Foa Is Part Of A Suite Of Innovation Grants To Nurture Initial Translational Efforts (Ignite) To Advance Projects To The Point Where They Can Meet The Entry Criteria For The Blueprint Neurotherapeutics Network Or Other Translational Programs. NATIONAL INSTITUTES OF HEALTH NIH OER WebmasterOERWebmaster03@od.nih.gov Tender Notice International Competitive Bidding PAR-25-058 United States of America GT-109082513
|
|||
NAICS | ||||
CPVS | ||||
UNSPSC | ||||
Regions | ||||
Sectors | ||||
URL | ||||
Share |
Title |
---|
Innovation Grants To Nurture Initial Translational Efforts (Ignite): Neurotherapeutic Agent Characterization And In Vivo Efficacy Studies (R61 R33 Clinical Trial Not Allowed) Tender Notice International Competitive Bidding |
Country |
Language |
English |
Organization |
Published Date |
23.10.2024 |
Deadline Date |
20.10.2027 |
Overview |
Innovation Grants To Nurture Initial Translational Efforts (Ignite): Neurotherapeutic Agent Characterization And In Vivo Efficacy Studies (R61 R33 Clinical Trial Not Allowed) Reissue Par-21-122. This Nofo Provides Funding To Conduct Pharmacodynamic, Pharmacokinetic, And In Vivo Efficacy Studies To Demonstrate That Proposed Therapeutic Agent(S) Have Sufficient Biological Activity To Warrant Further Development To Treat Neurological Or Neuromuscular Disorders That Fall Under The Ninds Mission. Therapeutic Agents Include Small Molecules, Biologics Or Biotechnology-Derived Products. This Foa Is Part Of A Suite Of Innovation Grants To Nurture Initial Translational Efforts (Ignite) To Advance Projects To The Point Where They Can Meet The Entry Criteria For The Blueprint Neurotherapeutics Network Or Other Translational Programs. NATIONAL INSTITUTES OF HEALTH NIH OER WebmasterOERWebmaster03@od.nih.gov Tender Notice International Competitive Bidding PAR-25-058 United States of America GT-109082513 |
NAICS |
Other Direct Insurance (except Life Direct Insurance (except Life Direct Life International |
CPVS |
Networks Networking, Internet and intranet software development services Nuclear, biological, chemical and radiological protection equipment Blueprints Networking, Internet and intranet software package |
UNSPSC |
Suite Financial Instruments, Products, Contracts and Agreements Airport Maps, Networks (GIS), Studies |
Regions |
APEC Countries North America Northern America |
Sectors |
Environment and Pollution-Recycling Postal and Courier Services Printing and Publishing Travel and Tourism Defence and Security Electricity Technology Hardware and Equipment Construction Energy-Power and Electrical Computer Hardwares and Consumables Marine |
URL |
Share |
To be notified
when a tender matching your filter is
published
To Follow
Tenders
Add New Tender Alert
To Follow
Contracts
Add New Contract Alert
To Follow
Fairs
Add New Fair Alert
Similar Tenders